Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01148030 · ClinicalTrials.gov registry record
Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change
A clinical trial, sponsored by 3M.
- Terminated
- Registry status
- 333
- Enrollment target
NCT01148030 is a clinical trial that was terminated before completion, run by 3M. The registered enrollment target is 333 participants.
The verdict
NCT01148030 was terminated before completion, sponsored by 3M.
- TERMINATED
- Registry status
- 333 participants
- Enrollment target
Study Summary
Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will receive treatment to reduce the number of microorganisms in their nose prior to surgery. After surgery, the subjects will be observed for any surgical site infections.
Interventions
- DRUG 3M Skin and Nasal Antiseptic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01148030
The ClinicalTrials.gov registry entry for NCT01148030 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 3M, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 3M Skin and Nasal Antiseptic is the first listed.
NCT01148030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01148030 about?
NCT01148030 is a clinical study titled "Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care Change". Patients presenting in the Emergency Department or admitted to the hospital with displaced hip fractures who require hemiarthroplasty or open reduction internal fixation or with spinal instability/fractures in need of urgent surgical intervention will receive treatment to reduce the number of microo...
What is the current status of trial NCT01148030?
This trial is currently terminated. The enrollment target is 333 participants. The study started on 2010-06. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01148030?
The interventions under investigation include: 3M Skin and Nasal Antiseptic (DRUG).
Who is sponsoring clinical trial NCT01148030?
This trial is sponsored by 3M, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.